Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors.Scheiper, B., Matter, H., Steinhagen, H., Bocskei, Z., Fleury, V., McCort, G.
(2011) Bioorg Med Chem Lett 21: 5480-5486
- PubMed: 21840218
- DOI: https://doi.org/10.1016/j.bmcl.2011.06.114
- Primary Citation of Related Structures:
- PubMed Abstract:
The control of hypertension and associated cardiovascular risk factors is possible by selective inhibition of the aspartyl protease renin due to its unique position in the renin-angiotensin system. Starting from a previously disclosed series of potent and nonchiral indole-3-carboxamides, we further explored this motif by structure-based drug design guided by X-ray crystallography in combination with efficient parallel synthesis. This resulted in the discovery of 4- or 6-azaindole derivatives with remarkable potency for renin inhibition. The best compound from these series showed an IC(50) value of 1.3 nM.
Sanofi-Aventis, Deutschland GmbH, Chemical and Analytical Sciences, Building G878, D-65926 Frankfurt, Germany.